SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
18-Nov-24 4:31 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Nov-24 | Payment of Exercise | 184 | $7.92 | $1,457.28 | (< 1%) 38.13K to 37.94K | |
16-Aug-24 4:52 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Aug-24 | Payment of Exercise | 184 | $7.02 | $1,291.68 | (< 1%) 39.15K to 38.97K | |
19-Jul-24 4:20 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 17-Jul-24 | Payment of Exercise | 558 | $7.69 | $4,291.02 | (1%) 39.71K to 39.15K | |
16-May-24 7:03 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-May-24 | Payment of Exercise | 184 | $8.36 | $1,538.24 | (< 1%) 39.89K to 39.71K | |
19-Apr-24 4:10 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 17-Apr-24 | Payment of Exercise | 558 | $10.34 | $5,769.72 | (1%) 40.45K to 39.89K | |
16-Feb-24 5:14 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Feb-24 | Payment of Exercise | 217 | $3.40 | $737.80 | (< 1%) 40.67K to 40.45K | |
19-Jan-24 4:24 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 17-Jan-24 | Payment of Exercise | 652 | $4.35 | $2,836.20 | (2%) 41.32K to 40.67K | |
16-Nov-23 7:43 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Nov-23 | Payment of Exercise | 735 | $5.08 | $3,733.80 | (2%) 42.05K to 41.32K | |
19-Oct-23 7:45 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 17-Oct-23 | Payment of Exercise | 2,232 | $5.48 | $12,231.40 | (5%) 44.29K to 42.05K | |
28-Sep-23 7:17 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 26-Sep-23 | Grant | 3,858 | -- | -- | 10% 40.43K to 44.29K | |
24-Mar-22 5:12 PM View: | Butterfly Network, Inc. (BFLY) | 22-Mar-22 | Grant | 54,789 | -- | -- | 17% 328.72K to 383.51K | |
08-Mar-22 4:59 PM View: | Butterfly Network, Inc. (BFLY) | 04-Mar-22 | Grant | 189,655 | -- | -- | 136% 139.07K to 328.72K | |
17-Feb-22 5:21 PM View: | Butterfly Network, Inc. (BFLY) | 16-Feb-22 | Market Sale | 16,677 | $5.95 | $99,253.20 | (11%) 155.75K to 139.07K | (6%) |